Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain

Indian Journal of Experimental Biology

Volumn 47, Issue 9, 2009, Pages 715-722

  Kumar, Puneet ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Glutathione; Huntington's disease; Memory; Oxidative; Sertraline; Stress

Indexed keywords

3 NITROPROPIONIC ACID; 3-NITROPROPIONIC ACID; ACETYLCHOLINESTERASE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; GLUTATHIONE; NEUROTOXIN; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE; SERTRALINE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BRAIN; BRAIN CORTEX; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; CORPUS STRIATUM; DRUG EFFECT; HIPPOCAMPUS; MALE; MAZE TEST; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT; WISTAR RAT;

ACETYLCHOLINESTERASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; CEREBRAL CORTEX; COGNITION DISORDERS; CORPUS STRIATUM; GLUTATHIONE; HIPPOCAMPUS; MALE; MAZE LEARNING; NEUROTOXINS; NITRO COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, WISTAR; SERTRALINE;

RATTUS;

EID: 70349339229     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bonelli RM & Hofmann P, A review of the treatment options for Huntington's disease, Expert Opin Pharmacother, 5 (2004) 767.
2. Beal MF, Mitochondrial dysfunction in neurodegenerative diseases, Biochim Biophys Acta, 1366 (1998) 211.
3. (Pubitemid 39457046) Tunez I, Montilla P, Del Carmen Munoz M, Feijoo M & Salcedo M, Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease, J Pineal Res, 37 (2004) 252.
4. Alston TA, Mela L & Bright HJ, 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase, Proc Natl Acad Sci U S A, 74 (1977) 3767.
5. Coles CJ, Edmondson DE & Singer TP, Inactivation of succinate dehydrogenase by 3-nitropropionate, J Biol Chem, 254 (1979) 5161.
6. Ludolph AC, He F, Spencer PS, Hammerstad J & Sabri M, 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin, Can J Neurol Sci, 18 (1991) 492.
7. Beal MF, Does impairment of energy metabolism results in excitotoxic neuronal death in neurodegenerative illness, Annals Neurology, 31 (1992) 119.
8. (Pubitemid 34816466) Barros DM, Izquierdo LA, Medina JH & Izquierdo I, Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats, Behav Pharmacol, 13 (2002) 215.
9. Pires JG, Bonikovski V & Futuro-Neto HA, Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice, Braz J Med Biol Res, 38 (2005) 1867.
10. Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B, Zhao M, Cadet JL, Wong J & Ross CA, Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease, Neurobiol Dis, 30 (2008) 312.
11. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA & Duan W, The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model, Exp Neurol, 210 (2008) 154.
12. (Pubitemid 34070638) Frautschy SA, Hu W, Kim P, Miller SA, White-Harris ME, Chu T & Cole G. M, Phenolic anti-inflammatory antioxidant reversal of Aß-induced cognitive deficits and neuropathology, Neurobiology Aging, 22 (2001) 993.
13. Sharma A & Kulkarni SK, Evaluation of learning and memory mechanisms employing plus maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatr, 16 (1991) 125.
14. Ellman GL, Tissue sulfhydryl groups, Arch Biochem Biophysics, 82 (1959) 70.
15. Zahler WL & Cleland WW, A specific and sensitive assay for disulfides, J Biol Chem, 243, (1968) 16.
16. Habig WH, Pabst MJ & Jakoby WS, Glutathione-S-transferase: The first enzymatic step in mercapturic acid formation, J Biol Chem, 249 (1974) 7130.
17. Ellman GL, Courtney KD, Andres V & Featherston RMA, New and rapid colorimetric determination of acetylcholinesterase activity, Biochem Pharmacol, 7 (1961) 88.
18. Gornall AG, Bardawill CJ & David M M, Determination of serum proteins by means of the biuret reaction, J Biol Chem, 177 (1949) 751.
19. Duckworth EA, Koutouzis TK, Borlongan CV, Gordon MN, Willing AE, Cahill DW & Sanberg PR, Rats receiving systemic 3-nitropropionic acid demonstrate impairment of memory in Morris water maze, Psychobiology, 27 (1999) 561.
20. Shear Deborah A, Haik Kristi L & Dunbar Gary L, Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats, Neuroreport, 11 (2000) 1833.
21. Patocka J, Bielavsky J, Cabal J & Fusek J, 3-Nitropropionic acid and similar nitrotoxins, Acta Medica (Hradec Kralove), 43 (2000) 9.
22. Kumar P, Padi SS, Naidu PS & Kumar A, Possible neuroprotective mechanisms of Curcumin in attenuating 3-Nitropropionic Acid-Induced Neurotoxicity, Methods Finding Exp Clinic Pharmacol, 29 (2007) 1.
23. Sunanda, Shankarnarayana Rao BS & Raju TR, Chronic restraint stress impairs acquisition and retention of spatial memory task in rats, Current Science, 79 (2000) 1581.
24. (Pubitemid 46237691) Titus AD, Shankaranarayana Rao BS, Harsha HN, Ramkumar K, Srikumar BN, Singh SB, Chattarji S & Raju TR, Hypobaric hypoxia-induced dendritic atrophy of hippocampal neurons is associated with cognitive impairment in adult rats, Neuroscience, 145 (2007) 265.
25. (Pubitemid 350225612) Bhagya V, Srikumar BN, Raju TR & Shankarnarayana BS, Neonatal clomipramine induced endogenous depression in rats is associated with learning impairment in adulthood. Behavioural Brain Research 187 (2008) 190.
26. Schmitt JA, Kruizinga MJ & Riedel WJ, Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors, J Psychopharmacol, 15 (2001) 173.
27. Sayre LM, Perry G & Smith MA, Oxidative stress and neurotoxicity, Chem Res Toxicol, 21 (2008) 172.
28. Borlongan CV, Kanning K, Poulos SG, Freeman TB, Cahill DW & Sanberg PR, Free radical damage and oxidative stress in Huntington's disease, J Fla Med Assoc, 83 (1996) 335.
29. Lin MT & Beal MF, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases, Nature, 443 (2006) 787.
30. Andersen JK, Oxidative stress in neurodegeneration: cause or consequence?, Nat. Med, 10 (2004) S18.
31. (Pubitemid 30641286) Schulz JB, Lindenau J, Seyfried J & Dichgans J, Glutathione, oxidative stress and neurodegeneration, Eur J Biochem, 267 (2000) 4904.
32. (Pubitemid 35174629) Rao AV & Balachandran B, Role of oxidative stress and antioxidants in neurodegenerative diseases, Nutr Neurosci, 5 (2002) 291.
33. (Pubitemid 29222959) Wuèllner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Loèschmann P, Schulz JB, Weller M & Klockgether T, Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function, Brain Res, 826 (1999) 53.
34. (Pubitemid 44401367) Mancuso M, Coppede F, Migliore L, Siciliano G & Murri L, Mitochondrial dysfunction, oxidative stress and neurodegeneration, J Alzheimers Dis, 10 (2006) 59.
35. Khanna P & Nehru B, Antioxidant enzymatic system in neuronal and glial cells enriched fractions of rat brain after aluminum exposure, Cell Mol Neurobiol, 27 (2007) 959.
36. (Pubitemid 44473250) Nehru B & Bhalla P, Reversal of an aluminium induced alteration in redox status in different regions of rat brain by administration of centrophenoxine, Mol Cell Biochem, 290 (2006), 185.
37. Shinomol GK & Muralidhara, Effect of Centella asiatica leaf powder on oxidative markers in brain regions of prepubertal mice in vivo and its in vitro efficacy to ameliorate 3-NPA-induced oxidative stress in mitochondria, Phytomedicine, 2008 (in press)
38. (Pubitemid 41225331) Tariq M, Khan HA, Elfaki I, Al Deeb S & Al Moutaery K, Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP) -induced experimental Huntington's disease in rats, Brain Res Bull, 67 (2005) 161.
39. Ranen NG, Lipsey JR, Treisman G & Ross CA, Sertraline in the treatment of severe aggressiveness in Huntington's disease, J Neuropsychiatry Clin Neurosci, 8 (1996) 338.
40. (Pubitemid 46295149) Eren I, Naziroǧlu M, Demirdaş A, Celik O, Uǧuz AC, Altunbaşak A, Ozmen I & Uz E, Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat, Neurochem Res, 32 (2007) 497.
41. (Pubitemid 46817468) Eren I, Naziroǧlu M & Demirdaş A, Protective effects of lamotrigine, aripiprazole and escitalopram on depressioninduced oxidative stress in rat brain, Neurochem Res, 32 (2007) 1188.
42. (Pubitemid 47374675) Zafir A & Banu N, Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats, Eur J Pharmacol, 572 (2007) 23.
43. Muñoz-Castañeda JR, Montilla P, Padillo FJ, Bujalance I, Muñoz MC, Muntané J & Túnez I, Role of serotonin in cerebral oxidative stress in rats, Acta Neurobiol Exp (Wars), 66 (2006) 1.
44. Nibuya M, Morinobu S & Duman RS, Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments, J Neurosci, 15 (1995) 7539.
45. (Pubitemid 26154346) Nibuya M, Nestler EJ & Duman RS, Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus, J Neurosci, 16 (1996) 2365.
46. (Pubitemid 40476760) Rocca P, Calvarese P, Faggiano F, Marchiaro L, Mathis F, Rivoira E, Taricco B & Bogetto F, Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial, J Clin Psychiatry, 66 (2005) 360.
47. Srikumar BN, Raju TR & Shankaranarayana Rao BS. The involvement of cholinergic and noradrenergic systems in behavioural recovery following oxotremorine treatment to chronically stressed rats, Neuroscience, 143 (2006) 679.